The Good, the Bad, and the Uncertain in the Treatment of Schizophrenia

Learn the latest about personalized treatment of patients with schizophrenia.

John M. Kane, MD
Greg Mattingly, MD
Joseph P. McEvoy, MD
Format: Microsoft PowerPoint (.ppt)
File Size: 2.95 MB
Released: April 22, 2021

Acknowledgements

This activity is provided by Clinical Care Options, LLC

Contact Clinical Care Options

For customer support please email: customersupport@cealliance.com

Mailing Address
Clinical Care Options, LLC
12001 Sunrise Valley Drive
Suite 300
Reston, VA 20191

Produced in collaboration with
This program is supported by educational grants from
AbbVie Inc.
Intra-Cellular Therapies, Inc.
Neurocrine Biosciences, Inc.
Sunovion

Related Content

Slides from a presentation that educates clinicians on the identification and management of tardive dyskinesia.

Christoph U. Correll, MD Robert O. Cotes, MD Released: May 11, 2022

Slides from a presentation that educates clinicians on antipsychotic treatment of schizophrenia.

Christoph U. Correll, MD Robert O. Cotes, MD Released: May 11, 2022

Dr John Torous, MD: Digital Transformation in Mental Health at the Inaugural Psychiatry Summit 2022, from Clinical Care Options (CCO)

John Torous, MD Physicians: maximum of 1.0 AMA PRA Category 1 Credit Registered Nurses: 1.0 Nursing contact hour Pharmacists: 1.0 contact hour (0.1 CEUs) Physician Assistants: maximum of 1.0 hour of AAPA Category 1 CME credit Psychologists: 1.0 APA CE Credit Social Workers: 1.0 ACE CE Credit Released: April 25, 2022 Expired: April 24, 2023

Slides from a presentation that educates clinicians on tardive dyskinesia.

Christoph U. Correll, MD Released: March 23, 2022

Leaving the CCO site

You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.

Continue

Cookie Settings